BiotechTubeBiotechTube
Home/Immunocore/Ralph
R

Ralph

Executive (Title truncated in data)

Immunocore

Therapeutic Areas

OncologyInfectious DiseasesAutoimmune Diseases

Immunocore Pipeline

DrugIndicationPhase
KIMMTRAK (tebentafusp)Metastatic Uveal MelanomaApproved
IMC-F106CPRAME-positive Solid Tumors (e.g., NSCLC, Endometrial, Ovarian, Breast)Phase 3
IMC-I109VChronic Hepatitis B Virus (HBV) InfectionPhase 1
IMC-M113VHuman Immunodeficiency Virus (HIV)Phase 1
Undisclosed ImmTAAI candidatesAutoimmune DiseasesPreclinical

Leadership Team at Immunocore

BJ
Bahija Jallal, PhD
Chief Executive Officer
TC
Travis Coy
EVP, Chief Financial Officer and Head of Corporate Development
TS
Tina St. Leger
EVP, Chief Human Resources Officer
LH
Lily Hepworth
EVP, General Counsel and Company Secretary
View full Immunocore profile